Perkin GD - Search Results

1

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity.

Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R. Banati RB, et al. Among authors: perkin gd. Brain. 2000 Nov;123 ( Pt 11):2321-37. doi: 10.1093/brain/123.11.2321. Brain. 2000. PMID: 11050032

2

Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules.

Vora AJ, Kidd D, Miller DH, Perkin GD, Hughes RA, Ellis BA, Dumonde DC, Brown KA. Vora AJ, et al. Among authors: perkin gd. Mult Scler. 1997 Jun;3(3):171-9. doi: 10.1177/135245859700300301. Mult Scler. 1997. PMID: 9310962

3

Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.

Thompson AJ, Kennard C, Swash M, Summers B, Yuill GM, Shepherd DI, Roche S, Perkin GD, Loizou LA, Ferner R, et al. Thompson AJ, et al. Among authors: perkin gd. Neurology. 1989 Jul;39(7):969-71. doi: 10.1212/wnl.39.7.969. Neurology. 1989. PMID: 2544829 Clinical Trial.

4

Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytes.

Selmaj K, Plater-Zyberk C, Rockett KA, Maini RN, Alam R, Perkin GD, Rose FC. Selmaj K, et al. Among authors: perkin gd. Neurology. 1986 Oct;36(10):1392-5. doi: 10.1212/wnl.36.10.1392. Neurology. 1986. PMID: 2429234

5

Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha (TNF-alpha)-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expression.

Vora AJ, Perkin GD, McCoy T, Dumonde DC, Brown KA. Vora AJ, et al. Among authors: perkin gd. Clin Exp Immunol. 1996 Jul;105(1):155-62. doi: 10.1046/j.1365-2249.1996.d01-721.x. Clin Exp Immunol. 1996. PMID: 8697624 Free PMC article.

6

The effect of oral and intravenous methylprednisolone treatment on subsequent relapse rate in multiple sclerosis.

Sharrack B, Hughes RA, Morris RW, Soudain S, Wade-Jones O, Barnes D, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi HA, Farmer S, Frankel JP. Sharrack B, et al. Among authors: perkin gd. J Neurol Sci. 2000 Feb 1;173(1):73-7. doi: 10.1016/s0022-510x(99)00304-4. J Neurol Sci. 2000. PMID: 10675582 Clinical Trial.

7

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.

Barnes D, Hughes RA, Morris RW, Wade-Jones O, Brown P, Britton T, Francis DA, Perkin GD, Rudge P, Swash M, Katifi H, Farmer S, Frankel J. Barnes D, et al. Among authors: perkin gd. Lancet. 1997 Mar 29;349(9056):902-6. doi: 10.1016/s0140-6736(96)06453-7. Lancet. 1997. PMID: 9093250 Clinical Trial.

8

Controlled trial prednisolone in acute polyneuropathy.

Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Hughes RA, et al. Among authors: perkin gd. Lancet. 1978 Oct 7;2(8093):750-3. doi: 10.1016/s0140-6736(78)92644-2. Lancet. 1978. PMID: 80682 Clinical Trial.

9

Steroids in acute polyneuropathy.

Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Hughes RA, et al. Among authors: perkin gd. Lancet. 1978 Dec 23-30;2(8104-5):1383. doi: 10.1016/s0140-6736(78)92022-6. Lancet. 1978. PMID: 82884 Clinical Trial. No abstract available.

10

Prognosis in Guillain-Barré syndrome.

Winer JB, Hughes RA, Greenwood RJ, Perkin GD, Healy MJ. Winer JB, et al. Among authors: perkin gd. Lancet. 1985 May 25;1(8439):1202-3. doi: 10.1016/s0140-6736(85)92875-2. Lancet. 1985. PMID: 2860398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page